The Lancet Oncology · 2016 · 144 citations · 30 references
Public HealthBiostatisticsOncologyClinical Decision SupportPredictive AnalyticsSurvival AnalysisComputational Survival AnalysisPrognostic AssessmentProstate CancerSurvival ModelingSurvival OutcomesSurvival PredictionCancer Prognostic ModelingMetastasis PredictionMetastatic Castration-resistant Prostate CancerPrognostic Biomarker ModelingPrognostic Model ValidationPrognostic PredictionPrognostic Prediction ModelsProstate Cancer Prognosis
30
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
Philip W. Kantoff, Celestia S. Higano, Neal D. Shore et al. · New England Journal of Medicine · 2010 · 5.5K citations · Full text
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher, Karim Fizazi, Fred Saad et al. · New England Journal of Medicine · 2012 · 4.6K citations · Full text
Medicine, Oncology, Pharmacology +14
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Johann S. de Bono, Christopher J. Logothetis, Arturo Molina et al. · New England Journal of Medicine · 2011 · 4.4K citations · Full text
Medicine, Oncology, Pharmacology +17
Genomic Classification and Prognosis in Acute Myeloid Leukemia
Elli Papaemmanuil, Moritz Gerstung, Lars Bullinger et al. · New England Journal of Medicine · 2016 · 4.4K citations · Full text
Life Sciences, Genetics, Oncology +14